Health Policy Affairs

On Feb. 11, SIR submitted formal comments to Cigna regarding Medical Coverage Policy 0539, which addresses peripheral nerve stimulation (PNS) and peripheral nerve field stimulation. SIR emphasized that PNS is an evidence-based, minimally invasive, image-guided therapy supported by randomized controlled trials, FDA-cleared technologies and a favorable safety profile. SIR urged Cigna to recognize PNS as medically necessary for appropriately selected patients with chronic pain and to align its coverage criteria with current clinical evidence and regulatory standards.

SIR remains committed to advocating for patient access to safe, effective interventional therapies and will continue to engage with payers to support appropriate coverage policies.